Profile ng asset

Aramchol · Eocene Ltd. (EOCN)

Indikasyon
mga kanser sa atay at GI (tumor microenvironment-targeted antifibrotic)
KumpanyaEOCNEocene Ltd.

Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colore…

Nasa kalendaryo

Walang nakaiskedyul sa panahong ito.

Timeline

Pinakabago muna.

Nakarehistrong trial

Registry IDPhaseStatusPrimary completionEnrollmentSites
NCT02279524Phase 2Tapos naMay 22, 201824717 sa 78 site ay nasa United States
NCT01094158Phase 2Tapos naNob 1, 2011600 sa 11 site ay nasa United States
NCT06095986Phase 2BinawiSet 1, 202601 sa 1 site ay nasa United States
NCT02325492Phase 2ItinigilOkt 1, 2015100 sa 1 site ay nasa United States
NCT04104321Phase 3NakasuspindeDis 8, 20221572 sa 2 site ay nasa United States
NCT02684591Phase 2Tapos naPeb 1, 2018501 sa 1 site ay nasa United States
Aramchol · Eocene Ltd. (EOCN) — FDA Timeline at Readiness Checklist | SimianX AI